US approves first gene therapy for rare form of hearing loss

The U.S. FDA has approved the first gene therapy targeting OTOF‑related hearing loss, a rare genetic condition that affects children. The treatment could restore hearing in patients with this mutation, offering a new therapeutic option that may eventually become available in Nigeria and other African markets.

The FDA has approved a new gene therapy for hearing loss caused by OTOF gene mutations, a breakthrough treatment offering hope to affected children. Read More: https://punchng.com/us-approves-first-gene-therapy-for-rare-form-of-hearing-loss/